Allan T. van Oosterom

27.4k citations
89 papers · 21.9k indexed · 5 hit papers · h-index 32

Allan T. van Oosterom

88 papers receiving 21.4k citations

Hit Papers

KIT mutations and dose selection for imatinib in patients...65420002026200820174.0k8.0k12.0k

Peers

Allan T. van Oosterom
Comparison fields: 5 of 154
  • Gastroenterology 3.3k
  • Oncology 9.3k
  • Pulmonary and Respiratory Medicine 10.1k
  • Hepatology 1.9k
  • Cancer Research 2.8k
Replace M. van Glabbeke with:
M. van Glabbeke Belgium
Robert S. Benjamin United States
Patrick Schöffski Belgium
Yung‐Jue Bang South Korea
J. Wanders Netherlands
Ian Judson United Kingdom
Susan G. Arbuck United States
Yoon‐Koo Kang South Korea
Patrick Therasse Belgium
J. Milburn Jessup United States
Allan T. van Oosterom relative to M. van Glabbeke Belgium M. van Glabbeke's profile →
Citations per field
00.5×1.5×
M. van Glabbeke · 1×
Citations per year

Countries citing papers authored by Allan T. van Oosterom

Since Specialization
Citations

This map shows the geographic impact of Allan T. van Oosterom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan T. van Oosterom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan T. van Oosterom more than expected).

Fields of papers citing papers by Allan T. van Oosterom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan T. van Oosterom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan T. van Oosterom. The network helps show where Allan T. van Oosterom may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Allan T. van Oosterom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Allan T. van Oosterom Line = papers co-authored together Allan T. van Oosterom links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20078
2 200779
3
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trialbreakdown →
20061930
4 200655
5
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumoursbreakdown →
2006654
6 20069
7 200645
8 200510
9
Vascular Endothelial Growth Factor and Angiogenesisbreakdown →
20041491
10 200292
11 2002184
12
New Guidelines to Evaluate the Response to Treatment in Solid Tumorsbreakdown →
200013583
13 199626
14 199631
15 19966
16 199522
17 19929
18 19891
19 19894
20 198860

About Allan T. van Oosterom

Allan T. van Oosterom is a scholar working on Gastroenterology, Oncology and Reproductive Medicine, having authored 89 papers that have together received 21.9k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (14 papers), Gastrointestinal Tumor Research and Treatment (13 papers), Cancer Treatment and Pharmacology (11 papers), Ovarian cancer diagnosis and treatment (9 papers), Cancer therapeutics and mechanisms (8 papers), Chronic Myeloid Leukemia Treatments (8 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Lung Cancer Research Studies (7 papers). The work is most often cited by research in Gastroenterology (3.3k citations), Oncology (9.3k citations) and Pulmonary and Respiratory Medicine (10.1k citations). Allan T. van Oosterom has collaborated with scholars based in Belgium, Netherlands and United Kingdom. Frequent co-authors include Jaap Verweij, M. van Glabbeke, Michaele C. Christian, Patrick Therasse, J. Wanders, Susan G. Arbuck, Richard Kaplan, Elizabeth A. Eisenhauer, Larry Rubinstein and E. A. de Bruijn. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026